Skip Navigation

European Heart Journal 2002 23(22):1736-1737; doi:10.1053/euhj.2002.3311
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jilma, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jilma, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Surrogate markers to monitor efficacy of anticoagulants or antiplatelet drugs in atrial fibrillation

B. Jilma

Department of Clinical Pharmacology, Vienna University, Vienna, Austria

References

  1. Kamath S, Blann AD, Chin BSP. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J. 2002;23:1788–1795[Abstract/Free Full Text]
  2. Pernerstorfer T, Stohlawetz P, Stummvol G. Low-dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol. 1998;102:1229–1231[CrossRef][ISI][Medline]
  3. Kamath S, Blann AD, Lip GY. Platelets and atrial fibrillation. Eur Heart J. 2001;22:2233–2242[Free Full Text]
  4. Ganz DA, Lamas GA, Orav EJ. Age-related differences in management of heart disease: a study of cardiac medication use in an older cohort. Pacemaker Selection in the Elderly (PASE) Investigators. J Am Geriatr Soc. 1999;47:145–150[ISI][Medline]
  5. Loebstein R, Yonath H, Peleg D. Interindividual variability in sensitivity to warfarin—nature or nurture? Clin Pharmacol Ther. 2001;70:159–164[CrossRef][ISI][Medline]
  6. Hollenstein U, Homoncik M, Knöbl P. Acenocoumarol decreases tissue factor dependent coagulation during systemic inflammation in humans. Clin Pharmacol Ther. 2002;71:368–374[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jilma, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jilma, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?